Effect of Modified Qigesan on the Recurrence and Metastasis Rate and Quality of Life among Patients after Radical Resection of Esophageal Carcinoma
Yu-shuang ZHANG,Jing GAO,Hui-juan SHI,Dong-xuan SHI,Jing LI
DOI: https://doi.org/10.3969/j.issn.1007-9572.2018.10.020
2018-01-01
Chinese General Practice
Abstract:Objective To evaluate the effect of modified Qigesan on the recurrence and metastasis rate and quality of life among patients after radical resection of esophageal carcinoma.Methods We enrolled 332 cases undergoing radical resection of esophageal squamous-cell carcinoma (ESC) from Department of Chest Surgery,and Department of Traditional Chinese Medicine,Fourth Hospital of Hebei Medical University from December 2011 to December 2014.Based on patient's own selection of therapy,204 and 128 were assigned to the control group and TCM group,respectively.Regular followups were given to the controls after completing the postoperative adjuvant chemotherapy,and for the TCM group,treatment with modified Qigesan was given to stage Ⅰ ESC cases at 3 weeks after the surgery,and to stage Ⅱ and Ⅲ ESC cases after completing the postoperative adjuvant chemotherapy.The treatment with modified Qigesan lasted for 1 year or was stopped at the timing of recurrence and metastasis of ESC within 2 years.The follow-up (observation) period for all the patients was 2 years or was stopped at the timing of postoperative recurrence and metastasis of ESC within this period.The outcome indicators include disease-free survival time (DFS),1-and 2-year recurrence and metastasis rate,score evaluated by Chinese version of EORTC Quality of Life Questionnaire Core 30 (QLQ-C30),score assessed by EORTC Quality of Life QuestionnaireOesophageal Cancer Module (QLQ-OES18),Karnofsky performance score (KPS) and weight change.Results Compared with the control group,TCM group showed a longer DFS and lower 1-year recurrence/metastasis rate (P＜0.05),but similar 2-year recurrence/metastasis rate (P＞0.05).Before intervention,two groups demonstrated no significant differences in the scores of general health status,physical,role,cognitive,emotional and social functioning,nausea and vomiting,pain,fatigue,dyspnoea,insomnia,constipation,diarrhea,financial difficulties,eating,trouble swallowing saliva,choked when swallowing,appetite loss,trouble with coughing,trouble talking (P＞0.05),but the TCM group showed higher scores of reflux and lower score of dysphagia;score of trouble with taste constipation and dry mouth between the two group (P＜0.05).After 3 months of intervention,the scores of role,cognitive,emotional and social functioning,pain,appetite loss,dyspnoea,insomnia,constipation,diarrhea,financial difficulties,dysphagia,eating,trouble swallowing saliva,dry mouth,trouble with taste,trouble with coughing,and trouble talking were similar in both groups (P＞0.05),but TCM group exhibited higher scores of general health status and physical functioning as well as lower scores of nausea and vomiting,fatigue,reflux and choked when swallowing (P＜0.05).Moreover,TCM group had better KPS (P＜0.05).However,there was no significant difference in weight change between the two groups (P＜0.05).Conclusion The modified Qigesan can reduce the recurrence and metastasis rate,prolong the DFS and improve the quality of life of patients after radical surgery for ESC.